Representative Publications

  1. Han Y, Zhou A, Li F, Wang Q, Xu L, Jia J. Apolipoprotein E ε4 allele is associated with vascular cognitive impairment no dementia in Chinese population. J Neurol Sci. 2020;409:116606.
  2. Jia L, Fu Y, Shen L, et al. PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer’s disease. Alzheimers Dement. 2020;16(1):178-191.
  3. Zhao T, Quan M, Jia J. Functional Connectivity of Default Mode Network Subsystems in the Presymptomatic Stage of Autosomal Dominant Alzheimer’s Disease. J Alzheimers Dis. 2020;73(4):1435-1444.
  4. Quan M, Zhao T, Tang Y, et al. Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer’s disease. Alzheimers Res Ther. 2020;12(1):14.
  5. Jia J, Wei C, Chen W, et al. Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer’s Disease. J Alzheimers Dis. 2020;74(1):199-211.
  6. Yang H, Wang W, Jia L, et al. The Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer’s Disease Mouse Model (PS1V97L). J Alzheimers Dis. 2020;74(1):261-275.
  7. Qin Q, Tang Y, Dou X, et al. Default mode network integrity changes contribute to cognitive deficits in subcortical vascular cognitive impairment, no dementia. Brain Imaging Behav. 2020.
  8. Xing Y, Wei P, Wang C, et al. TRanscranial AlterNating current Stimulation FOR patients with Mild Alzheimer’s Disease (TRANSFORM-AD study): Protocol for a randomized controlled clinical trial. Alzheimer’s Dement (New York, N Y). 2020;6(1):e12005.     
  9. Xing Y, Zhu Z, Du Y, et al. The Efficacy of COGnitive tRaining in patiEnts with Amnestic mild coGnitive impairmENT (COG-REAGENT): Protocol for a Multi-Center Randomized Controlled Trial. J Alzheimers Dis. 2020;75(3):779-787.
  10. Chen S, Jia J. Tenuifolin Attenuates Amyloid-β42-Induced Neuroinflammation in Microglia Through the NF-κB Signaling Pathway. J Alzheimers Dis. 2020;76(1):195-205.
  11. Jia L, Quan M, Fu Y, et al. Dementia in China: epidemiology, clinical management, and research advances. Lancet Neurol. 2020;19(1):81-92.
  12. Jia L, Fu Y, Shen L, et al. PSEN1, PSEN2, and APP mutations in 404 Chinese pedigrees with familial Alzheimer’s disease. Alzheimers Dement. 2020;16(1):178-191.
  13. Quan M, Zhao T, Tang Y, et al. Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer’s disease. Alzheimer’s research & therapy. 2020;12(1):14.
  14. Zhang J, Yue X, Luo H, et al. Illumination with 630 nm Red Light Reduces Oxidative Stress and Restores Memory by Photo-Activating Catalase and Formaldehyde Dehydrogenase in SAMP8 Mice. Antioxid Redox Signal. 2019;30(11):1432-1449.
  15. Zhang J, Chen B, Lu J, et al. Brains of rhesus monkeys display Aβ deposits and glial pathology while lacking Aβ dimers and other Alzheimer’s pathologies. Aging Cell. 2019;18(4):e12978.
  16. Xu LZ, Li BQ, Jia JP. DAPK1: a Novel Pathology and Treatment Target for Alzheimer’s Disease. Mol Neurobiol. 2019;56(4):2838-2844.
  17. Wang W, Hou TT, Jia LF, et al. Toxic amyloid-beta oligomers induced self-replication in astrocytes triggering neuronal injury. EBioMedicine. 2019;42:174-187.
  18. Tang Y, Xing Y, Zhu Z, et al. The effects of 7-week cognitive training in patients with vascular cognitive impairment, no dementia (the Cog-VACCINE study): A randomized controlled trial. Alzheimers Dement. 2019;15(5):605-614.
  19. Jia L, Qiu Q, Zhang H, et al. Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid. Alzheimers Dement. 2019;15(8):1071-1080.
  20. Wang ZH, Gong K, Liu X, et al. C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer’s disease. Nat Commun. 2018;9(1):1784.
  21. Jia J, Wei C, Chen S, et al. The cost of Alzheimer’s disease in China and re-estimation of costs worldwide. Alzheimers Dement. 2018;14(4):483-491.
  22. Jia J, Gauthier S, Pallotta S, et al. Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer’s disease. Alzheimers Dement. 2017;13(5):592-597.
  23. Ikram MA, Bersano A, Manso-Calderón R, et al. Genetics of vascular dementia – review from the ICVD working group. BMC Med. 2017;15(1):48.
  24. Ma Q, Zhao H, Tao Z, et al. MicroRNA-181c Exacerbates Brain Injury in Acute Ischemic Stroke. Aging Dis. 2016;7(6):705-714.
  25. Jia J, Zuo X, Jia XF, et al. Diagnosis and treatment of dementia in neurology outpatient departments of general hospitals in China. Alzheimers Dement. 2016;12(4):446-453.
  26. Jia J, Wei C, Liang J, et al. The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double-blind, placebo-controlled trial. Alzheimers Dement. 2016;12(2):89-99.
  27. Zhang Z, Song M, Liu X, et al. Delta-secretase cleaves amyloid precursor protein and regulates the pathogenesis in Alzheimer’s disease. Nat Commun. 2015;6:8762.
  28. Tang Y, Wang X, Jia J. Mercury poisoning presenting as sporadic Creutzfeldt-Jakob disease: a case report. Ann Intern Med. 2015;162(6):462-463.
  29. Meng R, Ding Y, Asmaro K, et al. Ischemic Conditioning Is Safe and Effective for Octo- and Nonagenarians in Stroke Prevention and Treatment. Neurotherapeutics. 2015;12(3):667-677.
  30. Mei Y, Jiang C, Wan Y, et al. Aging-associated formaldehyde-induced norepinephrine deficiency contributes to age-related memory decline. Aging Cell. 2015;14(4):659-668.
  31. Jia J, Zhou A, Wei C, et al. The prevalence of mild cognitive impairment and its etiological subtypes in elderly Chinese. Alzheimers Dement. 2014;10(4):439-447.
  32. Jia J, Wang F, Wei C, et al. The prevalence of dementia in urban and rural areas of China. Alzheimers Dement. 2014;10(1):1-9.
  33. Xing Y, Jia JP, Ji XJ, et al. Estrogen associated gene polymorphisms and their interactions in the progress of Alzheimer’s disease. PROGRESS IN NEUROBIOLOGY. 2013;111:53-74.
  34. Wang J, Zuo X, Dai Z, et al. Disrupted functional brain connectome in individuals at risk for Alzheimer’s disease. Biol Psychiatry. 2013;73(5):472-481.
  35. Leak RK, Zhang L, Luo Y, et al. Peroxiredoxin 2 battles poly(ADP-ribose) polymerase 1- and p53-dependent prodeath pathways after ischemic injury. Stroke. 2013;44(4):1124-1134.
  36. Meng R, Asmaro K, Meng L, et al. Upper limb ischemic preconditioning prevents recurrent stroke in intracranial arterial stenosis. Neurology. 2012;79(18):1853-1861.
  37. Gauthier S, Wu L, Rosa-Neto P, et al. Prevention strategies for Alzheimer’s disease. Transl Neurodegener. 2012;1(1):13.
  38. Shi FD, Jia JP. Neurology and neurologic practice in China. Neurology. 2011;77(22):1986-1992.
  39. Qin W, Jia L, Zhou A, et al. The -980C/G polymorphism in APH-1A promoter confers risk of Alzheimer’s disease. Aging Cell. 2011;10(4):711-719.
  40. Han Y, Wang J, Zhao Z, et al. Frequency-dependent changes in the amplitude of low-frequency fluctuations in amnestic mild cognitive impairment: a resting-state fMRI study. Neuroimage. 2011;55(1):287-295.
  41. Tang Y, Wang X, Ding Y, et al. Longitudinal lesion of the spinal cord in a patient with Vogt-Koyanagi-Harada disease. J Neurol Neurosurg Psychiatry. 2010;81(8):941-942.
  42. Zhou W, Xu D, Peng X, et al. Meta-analysis of APOE4 allele and outcome after traumatic brain injury. J Neurotrauma. 2008;25(4):279-290.
  43. Liu Z, Jia J. Novel human pathological mutations. Gene symbol: PRNP. Disease: dementia. Hum Genet. 2007;122(5):545.
  44. Zhou J, Meng R, Sui X, et al. Effects of administration styles of arsenic trioxide on intracellular arsenic concentration, cell differentiation and apoptosis. Haematologica. 2005;90(9):1277-1279.
  45. Jia J, Pollock M. Cold injury to nerves is not due to ischaemia alone. Brain. 1998;121 ( Pt 5):989-1001.
  46. Jia J, Pollock M. The pathogenesis of non-freezing cold nerve injury. Observations in the rat. Brain. 1997;120 ( Pt 4):631-646.